CT-2106
Jump to navigation
Jump to search
| CT-2106 | |
|---|---|
| Term | CT-2106 |
| Short definition | CT-2103 - A form of the cancer drug paclitaxel combined with a protein called polylumex that may have fewer side effects and work better than paclitaxel. It is being studied to treat breast cancer, ovarian cancer, lung cancer, and other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
CT-2106 - A form of the cancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin
External links
- Medical encyclopedia article on CT-2106
- Wikipedia's article - CT-2106
This MedicineGPT article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski